Current Research

Current2022-05-18T15:42:18+02:00
605, 2024

First Berlin – clearvise AG Research Update (06.05.2024)

First Berlin Equity Research hat ein Research Update zu clearvise AG (ISIN: DE000A1EWXA4) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 3,20 auf EUR 3,10.Zusamme...

605, 2024

First Berlin – clearvise AG Research Update (06/05/2024)

First Berlin Equity Research has published a research update on clearvise AG (ISIN: DE000A1EWXA4). Analyst Dr. Karsten von Blumenthal reiterated his BUY rating and decreased the price target from EUR 3.20 to EUR 3.10.Abstractclearvise has...

205, 2024

First Berlin – urban-gro, Inc. Research Update (02/05/2024)

First Berlin Equity Research has published a research update on urban-gro, Inc. (ISIN: US91704K2024). Analyst Ellis Acklin reiterated his BUY rating and maintained his USD 4.30 price target.AbstractAfter months of rumours and market specu...

3004, 2024

First Berlin – M1 Kliniken AG Research Update (30/04/2024)

First Berlin Equity Research has published a research update on M1 Kliniken AG (ISIN: DE000A0STSQ8). Analyst Ellis Acklin reiterated his BUY rating and maintained his EUR 18.00 price target.AbstractPreliminary 2023 results again featured ...

3004, 2024

First Berlin – M1 Kliniken AG Research Update (30.04.2024)

First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG (ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 18,00.ZusammenfassungDie vo...

Didn’t find what you’re looking for?

If you have unanswered questions about our services and are classified as an institutional investor, contact us to see how we can service your institution.

Nach oben